As of 3:59pm ET
| +0.05 / +1.08%|
The 4 analysts offering 12-month price forecasts for Sangamo Therapeutics Inc have a median target of 8.00, with a high estimate of 14.00 and a low estimate of 4.00. The median estimate represents a +70.21% increase from the last price of 4.70.
The current consensus among 6 polled investment analysts is to Buy stock in Sangamo Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.